Among the highlights, Charlotte Bocquet, a PhD student within the project under the supervision of Prof. Annabelle Dupont, presented a poster on the characterisation of rivaroxaban-associated intracerebral haematomas using an ex vivo model replicating the MISTIE procedure. This work is fully aligned with the objectives of WP2, dedicated to improving minimally invasive haematoma evacuation strategies.

Prof. Annabelle Dupont, co-lead of WP2, also delivered a well-received oral presentation on the identification of the SLC35D3 gene as a novel causative gene in a rare inherited platelet disorder. This multidisciplinary study combined cellular biology, electron microscopy, structural modelling and in silico analyses, with a notable contribution from Mickael Rosa.

TIPITCH’s presence at ISTH perfectly illustrates one of the project’s key strengths: bringing together world-class expertise at the intersection of haematology, neurology, imaging, fundamental research, and therapeutic innovation. We are proud to count among our consortium internationally recognised experts whose work is advancing knowledge far beyond the field of haemorrhagic stroke.

Beyond the scientific presentations, ISTH provided an excellent opportunity to share project advances, discuss findings with international experts, and strengthen links between basic, translational, and clinical research.

Congratulations to all the teams involved, and thank you for your continued commitment to advancing the scientific visibility and impact of TIPITCH.